CG Oncology, Inc. announced that it will issue 81,587,937 series F preferred shares at issue price of $1.2872 per share for the gross proceeds of $105,019,992.5064 in funding on July 27, 2023. The shares are convertible, participating, redeemable and cumulative. The shares carry cumulative dividend rate of 8% per annum.

The shares will be convertible in common shares at a price of $1.2872 per share. The shares are issued at $0.0001 par value per share.